Virus-mimetic systems for cancer diagnosis and therapy

Xihui Gao1, Junqiang Ding2, Qianqian Long1

  • 1School of Basic Medical Sciences & Center of Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University, Shanghai, China.

Insights

Virus-mimetic nanoparticles offer improved cancer therapy and diagnosis by mimicking viral structures for targeted drug delivery. These systems aim to overcome limitations of conventional methods, enhancing efficacy and reducing toxicity in oncologic disease treatment.

Area of Science:

  • Nanomedicine
  • Oncologic Disease
  • Biotechnology

Background:

  • Conventional drug delivery systems exhibit limitations in targeting tumors, leading to poor therapeutic outcomes.
  • Viruses possess inherent properties like efficient gene transfer, stability, and specific targeting, making them ideal models for delivery systems.
  • Existing nanoparticle-based delivery systems struggle with weak targeting, rapid elimination, and low stability.

Purpose of the Study:

  • To review virus-mimetic strategies for enhancing therapeutic and diagnostic agent delivery to tumor tissues.
  • To explore how mimicking viral assembly can create biocompatible vectors for targeted cancer treatment.
  • To discuss the challenges and potential of virus-mimetic systems in nanomedicine for oncologic disease.

Main Methods:

  • Review of scientific literature on virus features and their application in designing delivery systems.
  • Analysis of strategies that mimic viral geometry, composition, and assembly for nanoparticle development.
  • Discussion of methods for concentrating drugs or imaging agents in tumors using virus-mimetic vectors.

Main Results:

  • Virus-mimetic strategies leverage viral properties to design stable, targetable, and modifiable delivery vectors.
  • These systems show potential for improved drug/imaging agent accumulation in tumors.
  • Mimicking viral assembly offers a pathway to enhanced efficacy and reduced toxicity in cancer therapy and diagnosis.

Conclusions:

  • Virus-mimetic nanoparticle systems represent a promising approach to overcome limitations in current cancer nanomedicine.
  • Further research into these strategies could significantly improve therapeutic outcomes and diagnostic capabilities for oncologic diseases.
  • Addressing the challenges in virus-mimetic system development is crucial for their clinical translation.

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
880
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
630
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.1K